ISRCTN75277265进行中（未招募）未知
Controlled clinical trial on the clinical outcome of guided endodontics vs freehand drilling for the treatment of pulp canal obliteration
St Raphael Hospital0 个研究点目标入组 60 人开始时间: 2023年2月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Male or female patients attending the Endodontic Department at the University Hospitals of Leuven, Campus Sint-Rafaël with the need for complex endodontic treatment. To classify as complex, the tooth may present one or more of the following:
- •1. Pulp canal obliteration (PCO) or canal not seen on a periapical radiograph
- •2. Anatomical deviations (dens in dente or other) where localizing the root canal may be challenging or compromise the tooth by free-handed treatment
- •3. Present an obstruction in the canal
- •4. Resorption, either internal or external
- •5. Root perforation
- •6. Presenting symptoms and/or radiographic signs of apical periodontitis (AP)
排除标准
- •1. Patient unwilling or unable to comply with the endodontic treatment and follow-up periods
- •2. Tooth in need of extraction or with an unfavorable prognosis
研究者
相似试验
进行中（未招募）
1 期
Study on the IMPACT-treatment of cartilage defects (local damage to the cartilage) of the knee. In this treatment cells are obtained from the cartilage defect (from the damaged cartilage) and mixed with stromal cells from a donor. These cells are obtained and placed back in the defect during a single surgery. The primary goal of this study is to determine the effect of the IMPACT-treatment on pain and function of the knee.Cartilage defect of the femoral condyle or trochleaEUCTR2018-003470-27-NLMC Utrecht60
已完成
3 期
Randomized controlled trial on clinical outcomes and safety of Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) for focal articular cartilage lesions of the kneecartilage defect/ cartilage lesion10043237NL-OMON55402niversitair Medisch Centrum Utrecht60
进行中（未招募）
1 期
Controlled clinical trial to evaluate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhea-dominant irritable bowel syndrome (IBS-D) and patients with mixed-type irritable bowel syndrome (IBS-M)A confirmed diagnosis of irritable bowel syndrome (IBS-D or IBS-M) by a specialist in gastroenterology and/or internal medicine and/or general medicineMedDRA version: 20.0Level: LLTClassification code 10023002Term: Irritable bowelSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 26.0Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2019-000245-12-DERepha GmbH140
已完成
不适用
Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter studytype 2 diabetic patients with NAFLD/NASHJPRN-UMIN000015727Saga University55
已完成
不适用
Controlled clinical trial for evaluation of effects of the stretch for trigger fingertrigger fingerJPRN-UMIN000020120Sakura Orthopedic Hospital60